[Federal Register Volume 67, Number 202 (Friday, October 18, 2002)]
[Notices]
[Pages 64388-64389]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-26526]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Program Announcement 02098]


Expansion of HIV/AIDS Care Services in C[ocirc]te d'Ivoire; 
Notice of Award of Funds

A. Purpose

    The Centers for Disease Control and Prevention (CDC) announces the 
availability of fiscal year (FY) 2002 funds for a cooperative agreement 
program for the expansion of HIV/AIDS care services in the Republic of 
C[ocirc]te d'Ivoire.
    The purpose of this cooperative agreement is to strengthen and 
expand the community response to Human Immunodeficiency Virus (HIV/
AIDS) care services in the ten communities of Abidjan, the capital of 
C[ocirc]te d'Ivoire, and selected secondary cities throughout the 
country.

B. Eligible Applicants

    Applications may only be submitted by public and private non-profit 
and for profit-organizations, state and local governments or their bona 
fide agents, that currently conduct HIV/AIDS work in C[ocirc]te 
d'Ivoire.
    Applicants must have at least five years experience in HIV/AIDS 
work in C[ocirc]te d'Ivoire including: Community mobilization for 
prevention of HIV/AIDS and promotion of voluntary counseling and 
testing; successful working relationships with both local and national 
government offices such as the mayors' office and the Ministries of 
Health and AIDS; establishment of support groups for people living with 
AIDS (PLWA); knowledge and understanding of resources available to 
create referral networks for clinical and psycho-social support for 
PLWA and families.

    Note: Title 2 of the United States Code section 1611 states that 
an organization described in section 501(c)(4) of the Internal 
Revenue Code that engages in lobbying activities is not eligible to 
receive Federal funds constituting an award, grant, or loan.

C. Availability of Funds

    Approximately $200,000 is available in FY 2002 to fund this award. 
It is expected that the average award will begin on or about September 
30, 2002, and will be made for a 12-month budget period within a 
project period of up to three years. Annual funding estimates may 
change.
    Continuation awards within the approved project period will be made 
on the basis of satisfactory progress as evidenced by required reports 
and the availability of funds.

Use of Funds

    Funds received from this announcement will not be used for the 
purchase of antiretroviral drugs for treatment of established HIV 
infection (with the exception nevirapine in Prevention of Mother to 
Child Transmission (PMTCT) cases and with prior written approval), 
occupational exposures, and non-occupational exposures and will not be 
used for the purchase of machines and reagents to conduct the necessary 
laboratory monitoring for patient care.
    Applicants may contract with other organizations under these 
cooperative agreements, however, applicants must perform a substantial 
portion of the activities (including program management, operations and 
delivery of prevention services) for which funds are requested.
    The costs that are generally allowable in grants to domestic 
organizations are likewise allowable to foreign institutions and 
international organizations, with the following exceptions:
    Indirect Costs: With the exception of the American University, 
Beirut, the Gorgas Memorial Institute, and the World Health 
Organization (WHO), indirect costs will not be paid (either directly or 
through a sub-award) to organizations located outside the territorial 
limits of the United States or to international organizations 
regardless of their location.
    All requests for funds, including the budget contained in the 
application, shall be stated in U.S. dollars. Once an award is made, 
the Department of Health and Human Services (DHHS)

[[Page 64389]]

will not compensate foreign grantees for currency exchange fluctuations 
through the issuance of supplemental awards.
    No funds appropriated under this Act shall be used to carry out any 
program of distributing sterile needles or syringes for the hypodermic 
injection of any illegal drug.

D. Where To Obtain Additional Information

    This and other CDC announcements can be found on the CDC home page 
Internet address http://www.cdc.gov/. Click on ``Funding'' then 
``Grants and Cooperative Agreements.''
    If you have questions after reviewing the contents of all the 
documents, business management technical assistance may be obtained 
from: Cynthia Collins, Grants Management Specialist, Grants Management 
Branch, Procurement and Grants Office, Centers for Disease Control and 
Prevention, 1600 Clifton Road, Mailstop E-15, Atlanta, GA 30333. 
Telephone number: (770) 488-2757. E-Mail: [email protected].
    For program technical assistance, contact: Karen Ryder, MPH, CDC/
HIV, 2010 Abidjan Place, Dulles, VA 20189-2010. Telephone: (404) 639-
0911. E-Mail address: [email protected].

    Dated: October 9, 2002.
Edward J. Schultz,
Deputy Director, Procurement and Grants Office, Center for Disease 
Control and Prevention.
[FR Doc. 02-26526 Filed 10-17-02; 8:45 am]
BILLING CODE 4163-18-P